Ubs Asset Management Americas Inc Royalty Pharma PLC Transaction History

Ubs Asset Management Americas Inc

$446 Billion
Q3 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 3,129,936 shares of RPRX stock, worth $123 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,129,936

Previous 4,076,999 23.23%

Holding current value

$123 Million

Previous $147 Million 24.83%

% of portfolio

0.02%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$34.9 - $37.91 $33.1 Million - $35.9 Million	-947,063 Reduced 23.23%	3,129,936 $110 Million
Q2 2025 Aug 14, 2025	BUY	$30.85 - $36.14 $37.9 Million - $44.4 Million	1,229,065 Added 43.16%	4,076,999 $147 Million
Q1 2025 May 19, 2025	BUY	$25.75 - $33.86 $5.82 Million - $7.65 Million	226,048 Added 8.62%	2,847,934 $88.7 Million
Q4 2024 Feb 14, 2025	SELL	$24.28 - $28.39 $8.51 Million - $9.95 Million	-350,315 Reduced 11.79%	2,621,886 $66.9 Million
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $4.48 Million - $5.12 Million	174,874 Added 6.25%	2,972,201 $84.1 Million

Q2 2024 Aug 13, 2024	BUY	$26.26 - $29.9 $24.5 Million - $27.9 Million	933,604 Added 50.09%	2,797,327 $73.8 Million
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $10.4 Million - $11.9 Million	379,518 Added 25.57%	1,863,723 $56.6 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $3.61 Million - $4.02 Million	137,644 Added 10.22%	1,484,205 $41.7 Million
Q3 2023 Nov 13, 2023	BUY	$26.26 - $31.38 $4.98 Million - $5.95 Million	189,561 Added 16.38%	1,346,561 $36.5 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $2.17 Million - $2.61 Million	66,299 Added 6.08%	1,157,000 $41.7 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $2.4 Million - $2.7 Million	61,294 Added 5.95%	1,090,701 $43.1 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $3.7 Million - $4.14 Million	92,791 Added 9.91%	1,029,407 $41.4 Million
Q2 2022 Aug 12, 2022	SELL	$37.53 - $44.22 $66,240 - $78,048	-1,765 Reduced 0.19%	936,616 $39.4 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $850,304 - $963,345	22,699 Added 2.48%	938,381 $36.6 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $11.4 Million - $13.8 Million	325,543 Added 55.16%	915,682 $36.5 Million
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $603,682 - $705,576	16,704 Added 2.91%	590,139 $21.3 Million
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $2.21 Million - $2.59 Million	55,481 Added 10.71%	573,435 $23.5 Million
Q1 2021 May 14, 2021	BUY	$42.34 - $52.82 $21.9 Million - $27.4 Million	517,954 New	517,954 $22.6 Million

Others Institutions Holding RPRX

# of Institutions

536

Shares Held

304M

Call Options Held

1.34M

Put Options Held

252K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Royalty Pharma PLC Transaction History